To test the hypothesis that human neuroblastomas arising in the TATA/TATA background have low LMO1 expression and, as in the zebrafish model, are enriched for neuroblastomas relying on the mesenchymal rather than the adrenergic CRC, we used a new publicly available data set from the Gabriella Miller Kids First (GMKF) Data Research Program (https://commonfund.nih.gov/kidsfirst/). The gene discussed is LMO1; the disease is colorectal carcinoma.